Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Cerilliant
Federal Trade Commission
Farmers Insurance
Daiichi Sankyo
Healthtrust
UBS
Deloitte
Fuji

Generated: January 19, 2018

DrugPatentWatch Database Preview

ENTOCORT EC Drug Profile

« Back to Dashboard

Which patents cover Entocort Ec, and when can generic versions of Entocort Ec launch?

Entocort Ec is a drug marketed by Perrigo Pharma Intl and is included in one NDA.

The generic ingredient in ENTOCORT EC is budesonide. There are twenty-one drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Drug patent expirations by year for ENTOCORT EC
Pharmacology for ENTOCORT EC
Medical Subject Heading (MeSH) Categories for ENTOCORT EC

US Patents and Regulatory Information for ENTOCORT EC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Pharma Intl ENTOCORT EC budesonide CAPSULE;ORAL 021324-001 Oct 2, 2001 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ENTOCORT EC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Perrigo Pharma Intl ENTOCORT EC budesonide CAPSULE;ORAL 021324-001 Oct 2, 2001 ➤ Subscribe ➤ Subscribe
Perrigo Pharma Intl ENTOCORT EC budesonide CAPSULE;ORAL 021324-001 Oct 2, 2001 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ENTOCORT EC
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Enteric Coated Capsules 3 mg ➤ Subscribe 2/1/2008

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
Cantor Fitzgerald
Julphar
Harvard Business School
Fuji
Daiichi Sankyo
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot